Overview

Pharmacokinetics of Sildenafil in Premature Infants

Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn more about the safety and dosing of sildenafil in infants.
Phase:
Phase 1
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborators:
Duke University
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
The Emmes Company, LLC
The EMMES Corporation
Treatments:
Sildenafil Citrate